Advertisement

Topics

InterMed Discovery GmbH Company Profile

08:55 EST 20th January 2017 | BioPortfolio

InterMed Discovery is a world class natural product lead-discovery company, driving innovation through the generation of novel product candidates for the life science, food and cosmetics industries. Using one of the most powerful validated natural product discovery engines, InterMed Discovery generates proprietary product pipelines of functional ingredients and also supports partners in research and lead generation. Biologically characterised product leads are identified using IMD BIOPROFILING® and NPSilico®, which together comprise a proprietary bioinformatics platform drawing on screening results compiled over many years, complemented by primary biological and chemical research on natural products. InterMed Discovery adds to this the industry’s largest collections of pure compounds, sample fractions and mixtures as its source for potential natural product leads. The Company is located in Dortmund, Germany and was founded in 2006 as a management buyout of the Natural Products Research Unit of Bayer Healthcare. IMD entered into strategic cooperations with companies such as Cognis GmbH (now BASF SE) and Biotropics Malaysia Berhad. Further information on InterMed Discovery can be found at www.intermed-discovery.com.


News Articles [759 Associated News Articles listed on BioPortfolio]

InterMed Discovery GmbH Mergers Acquisitions MA, Partnerships Alliances and Investment Report Prices from USD $350

SummaryMarketLine's Company Mergers Acquisitions MA, Partnerships Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an orga...

Royalties under patent licence agreements: can they remain payable even if the licensed patents(s) are revoked or not practised? Lessons from Genentech Inc v Hoechst GmbH & Sanofi-Aventis Deutschland GmbH

Précis In its recent decision in Genentech Inc v Hoechst GmbH & Sanofi-Aventis Deutschland GmbH (7 July 2016), the Court of Justice of the EU (“CJEU”) has ruled that an obligati...

UGISense, Lead Discovery team up to develop antisense candidates

UGISense AG signed a deal to develop antisense candidates with Lead Discovery Center GMBH (LDC).

Gardner Denver Medical to Acquire the ILS GmbH and Zinsser Analytic GmbH

Gardner Denver’s Medical Group has announced the acquisition of Innovative Labor Systeme GmbH and Zinsser Analytic GmbH. ILS is a leading manufacturer of glass syringes and a global supplier to...

GILUPI GmbH Receives ISO 13485 Certification for Manufacturing and Distribution of Cell Separation Devices

After the 68th AACC Annual Scientific Meeting & Clinical Lab Expo (AACC), GILUPI GmbH announces that it has received EN ISO 13485 certification for its German operations. This ISO 13485 certifica...

UGISense raises €1.2mm in Series A financing

Antisense technology developer UGISense AG raised €1.2mm ($1.3mm) in Series A financing from private investors, including partner Lead Discovery Center GMBH (LDC).

Domainex is first UK CRO to invest in NanoTemper’s novel Drug Discovery technology

NanoTemper Technologies Gmbh has scored custom from the UK CRO Domainex Ltd., which is using its MicroScale Thermophoresis technology for speedier, “higher quality clinical candidates”.

Oxford Global’s 3rd Annual Drug Discovery USA Congress – Final Agenda

Have you seen the final agenda for our 3rd Annual Drug Discovery USA Congress? Our expert panel of speakers will address the current strategies for directed discovery, including the resurgence of phe...

PubMed Articles [602 Associated PubMed Articles listed on BioPortfolio]

Assessment of biopsychosocial complexity and health care needs: measurement properties of the INTERMED self-assessment version (IMSA).

The INTERMED Self-Assessment questionnaire (IMSA) was developed as an alternative to the observer-rated INTERMED (IM) to assess biopsychosocial complexity and health care needs. We studied feasibility...

Evaluation of the German Version of the "INTERMED-Self-Assessment"-Questionnaire (IM-SA) to Assess Case Complexity.

Introduction: The INTERMED- interview (IM-CAG=INTERMED complexity assessment grid) is a well validated instrument for the identification of complex patients in need of integrated health care (score ...

Learning from the past for TB drug discovery in the future.

Tuberculosis drug discovery has shifted in recent years from a primarily target-based approach to one that uses phenotypic high-throughput screens. As examples of this, through our EU-funded FP7 colla...

A renaissance of neural networks in drug discovery.

Neural networks are becoming a very popular method for solving machine learning and artificial intelligence problems. The variety of neural network types and their application to drug discovery requir...

Dermoscopy, confocal microscopy and optical coherence tomography for the diagnosis of bedbug infestation.

A 33 year-old woman suffering from rosacea presented with outbreaks of itchy plaques on her face and limbs that curiously improved when she was far from home during summer holidays (Fig. 1). Dermoscop...

Clinical Trials [116 Associated Clinical Trials listed on BioPortfolio]

Discovery Elbow Multi-Center Prospective Study

The purpose of this prospective clinical trial is to document the performance and clinical outcomes of Biomet Discovery Elbow.

Effects of a Multi-Faceted Psychiatric Intervention Targeted at the Complex Medically Ill: a Randomized Controlled Trial

Background: somatic patients with psychiatric co-morbidities are a major challenge for the health care system. This study evaluated a psychiatric intervention targeted at the complex medic...

Bioequivalence Study of Linagliptin From Prevaglip 5 mg Tablets(Eva Pharma, Egypt) and Trajenta 5 mg Tablets (Boehringer Ingelheim International GmbH, Germany)

An open label randomized, single dose, two-way crossover bioequivalence study to determine the bioequivalence of Linagliptin from Prevaglip 5 mg tablets(Eva pharma for Pharmaceuticals & Me...

A Clinical Investigation of the Discovery™ Elbow System

The purpose of this study is to perform a five-year, multi-center prospective evaluation of the Discovery™ Elbow System for outcome and durability. Relief of pain and restoration of fun...

Protein Biomarker Discovery and Validation in Chronic Obstructive Pulmonary Disease (COPD) And Asthma

The purpose of the study is to better understand the function of asthma and COPD, and response to therapy. There are two Phases to this study broken into two arms. In Phase I, our propose ...

Companies [1062 Associated Companies listed on BioPortfolio]

InterMed Discovery GmbH

InterMed Discovery is a world class natural product lead-discovery company, driving innovation through the generation of novel product candidates for the life science, food and co...

Discovery Health

Discovery Health Media includes the Discovery Health and FitTV television networks and online assets, including www.discoveryhealth.com, as well as its Continuing Medical Education (CME) business and ...

Argenta Discovery Ltd.

Argenta Discovery is a privately held drug discovery company, applying its integrated medicinal chemistry, biology, ADMET and CADD expertise to drive drug discovery programmes. Argenta has a successfu...

Pyxis Discovery B.V.

The ambition of Pyxis Discovery is to be the preferred chemistry service provider for companies that are active in small molecule drug discovery. Pyxis Discovery's Smart approach of designing and ...

Med Discovery SA

Med Discovery’s mission is the discovery and development of highly specific protein drugs to treat uro-genital cancers. By combining biological drug discovery expertise with a strong in-house knowle...

More Information about "InterMed Discovery GmbH" on BioPortfolio

We have published hundreds of InterMed Discovery GmbH news stories on BioPortfolio along with dozens of InterMed Discovery GmbH Clinical Trials and PubMed Articles about InterMed Discovery GmbH for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of InterMed Discovery GmbH Companies in our database. You can also find out about relevant InterMed Discovery GmbH Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Food
Food is any substance consumed to provide nutritional support for the body. It is usually of plant or animal origin, and contains essential nutrients, such as carbohydrates, fats, proteins, vitamins, or minerals. The substance is ingested by an organism ...

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...


Corporate Database Quicklinks



Searches Linking to this Company Record